Written question asked by Lord Kamall (Conservative) on Monday, 9 March 2026, in the House of Lords. It was due for an answer on Monday, 23 March 2026. It was answered by Baroness Merron (Labour) on Tuesday, 24 March 2026 on behalf of the Department of Health and Social Care.
Cancer: Children and Young People
- Question
-
To ask His Majesty's Government what consideration they have given to allowing children and young people with non-malignant conditions who travel long distances to receive stem cell transplants and chimeric antigen receptor T-cell therapy access to the young cancer patient travel fund announced as part of the National Cancer Plan for England, published on 4 February.
- Answer
-
The commitment to fund travel costs of up to £10 million per year to support children and young people with cancer is a key priority for the National Cancer Plan.
The Department is currently working with its partners to define the scope and parameters of the scheme and further detail will be announced in due course.
Secondary information
- Type
- Written question
- Reference
- HL15339
- Session
- 2024-26
- Related items
- Subjects
- Travel Children Cancer Finance Young people Immunotherapy
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-04-20 14:03:55 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-26/HL15339
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-26/HL15339
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-26/HL15339